November 2015 Issue Table Of Contents

From The Editor

• Will Biologic Growth Overwhelm Your Ability To Manufacture?

Feature Article

• How Biogen Is Preparing For The Biologics Tidal Wave

The Enterprisers

• Codagenix, A Tiny Start-Up Ready To Take On The Goliaths Of The Vaccine Industry

Capitol Perspectives

• Focus On Pricing Puts Rx Industry On Defensive

Companies To Watch

• Companies To Watch: Vascular Pharmaceuticals

Deeper Dive

• Why A Seasoned Management Team Is The Ultimate Competitive Advantage In Biopharma

Outsourcing Insights

• The Buzz Around Oncology — Update On Biologics Approvals

Inside The Industry

• How One Biopharma Improved Patient & Clinical Site Relationships
• Redefining Clinical Research In The Age Of Genomic Science
• Compassionate Use Trials Complex, But Improving

Industry Leader

• A Life Science Manufacturing Executive’s Role In Establishing A Quality Culture
• How Much Transparency Is Too Much With Clinical Trials?

Leadership Lessons

• The Hidden Factor Of Leadership

Ask The Board

• How Can Manufacturing Executives Prevent Supply Chain Partners From Becoming Bottlenecks To Quality Manufacturing?
• What Are The Components Of A Regulatory Intelligence Function In Pharma?
• What Advice Do You Have For Preventing/ Minimizing A Counterfeit Situation From Disrupting Your Manufacturing Process?